and migraine and establish whether it is linked to the paroxysmal non-kinesigenic dyskinesia (PNKD) locus on chromosome 2q33–35, the familial hemiplegic migraine (FHM) locus on chromosome 19p, or the ...
Correspondence to: Professor AJ Lees, Reta Lila Weston Institute of Neurological Studies, Royal Free and University College London Medical School, Windeyer Institute of Medical Science, 46 Cleveland ...
Significantly increased risk for tardive dyskinesia seen with doses of greater than 75mg/day at last prescription and as maximum dose. HealthDay News — Antipsychotics at doses greater than 75mg ...
Tardive dyskinesia is a drug-induced neurological disorder characterized by involuntary movements of the face and body. The condition develops as a side effect of long-term use of antipsychotics and ...
Summary: Researchers have uncovered a new understanding of levodopa-induced dyskinesia, a common side effect in Parkinson’s patients, revealing that the motor cortex disconnects rather than directly ...
Dyskinesia hampers the quality of life for most Parkinson's disease patients following several years of therapy. However, the severity of L-Dopa-induced dyskinesia (LID) varies between patients ...
Another study focused on the clinical characterization of paroxysmal dyskinesia in Welsh terriers, revealing that affected dogs exhibited episodes of sustained hypertonicity and abnormal postures ...
As the condition advances, involuntary twisting or writhing movements can develop. These movements, described as dyskinesias, are caused by medications used to treat Parkinson's disease, most commonly ...